Deborah Dunsire
CIK 1332764 · President, CEO · last filed 2026-05-18
Deborah Dunsire is a President, CEO who has filed 146 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for RARE, was dated May 18, 2026. Across all open-market trades the lifetime net is −$1.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $939.1K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$939.1K
5
146
-$1.48M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RARE | Director | 38,566 | $24.35 | $939.1K | $0 | 11 | 2026-05-18 |
| MCK | Director | — | $784.05 | — | $0 | 3 | 2025-07-31 |
| SYRS | Director | 12,000 | $0.00 | $5 | $0 | 6 | 2024-06-07 |
| ALLERGAN INC (AGN) Delisted | Director | 35,462 | — | — | $11.8K | 108 | 2015-02-19 |
| MILLENNIUM PHARMACEUTICALS INC (MLNM) Delisted | President, CEO | 68,899 | — | — | -$1.50M | 11 | 2008-05-15 |
Recent Filings
146 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-18 | RARE | Grant (A) | +7,751 | $0 | EDGAR |
| 2025-07-31 | MCK | Grant (A) | — | $0 | EDGAR |
| 2025-05-19 | RARE | Grant (A) | +5,740 | $0 | EDGAR |
| 2024-08-01 | MCK | Grant (A) | — | $0 | EDGAR |
| 2024-06-20 | RARE | Grant (A) | +5,345 | $0 | EDGAR |
| 2024-06-07 | SYRS | Grant (A) | — | $0 | EDGAR |
| 2024-06-04 | MCK | Grant (A) | — | $0 | EDGAR |
| 2024-06-04 | SYRS | Exer (M) | +4,000 | $0 | EDGAR |
| 2023-06-09 | RARE | Grant (A) | +3,860 | $0 | EDGAR |
| 2023-06-02 | SYRS | Grant (A) | — | $0 | EDGAR |